Cargando…

Potential Novel Biomarkers in Chronic Graft-Versus-Host Disease

Prognostic, diagnostic or predictive biomarkers are urgently needed for assessment of chronic graft-versus-host disease (cGvHD), a major risk for patients undergoing allogeneic hematopoietic stem cell transplantation. The main goal of this review generated within the COST Action EUROGRAFT “Integrate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Crossland, Rachel E., Perutelli, Francesca, Bogunia-Kubik, Katarzyna, Mooney, Nuala, Milutin Gašperov, Nina, Pučić-Baković, Maja, Greinix, Hildegard, Weber, Daniela, Holler, Ernst, Pulanić, Dražen, Wolff, Daniel, Dickinson, Anne M., Inngjerdingen, Marit, Grce, Magdalena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786047/ https://www.ncbi.nlm.nih.gov/pubmed/33424849 http://dx.doi.org/10.3389/fimmu.2020.602547

Ejemplares similares

Complex interactions of cellular players in chronic Graft-versus-Host Disease
por: Gail, Laura Marie, et al.
Publicado: (2023)

Practice patterns in chronic graft-versus-host disease patient management and patient reported outcome measures across the EBMT allogeneic transplantation network
por: Perovic, Vladimir, et al.
Publicado: (2022)

Chronic graft-vs-host disease in 2016: a major challenge and an opportunity
por: Pulanić, Dražen, et al.
Publicado: (2016)

Von Willebrand Factor, Factor VIII, and Other Acute Phase Reactants as Biomarkers of Inflammation and Endothelial Dysfunction in Chronic Graft-Versus-Host Disease
por: Lelas, Antonela, et al.
Publicado: (2021)

Review of Genetic Variation as a Predictive Biomarker for Chronic Graft-Versus-Host-Disease After Allogeneic Stem Cell Transplantation
por: Partanen, Jukka, et al.
Publicado: (2020)

B-Cell-Based and Soluble Biomarkers in Body Liquids for Predicting Acute/Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
por: Juric, Mateja Kralj, et al.
Publicado: (2017)

Editorial: Cellular Therapies: Past, Present and Future
por: Dressel, Ralf, et al.
Publicado: (2018)

Significant Associations of IgG Glycan Structures With Chronic Graft-Versus-Host Disease Manifestations: Results of the Cross-Sectional NIH Cohort Study
por: Prenc, Ema, et al.
Publicado: (2021)

Use of the NIH consensus criteria in cellular and soluble biomarker research in chronic graft-versus-host disease: A systematic review
por: Milosevic, Emina, et al.
Publicado: (2022)

New Approaches for the Treatment of Chronic Graft-Versus-Host Disease: Current Status and Future Directions
por: Saidu, Nathaniel Edward Bennett, et al.
Publicado: (2020)

Profiling Tissue and Biofluid miR-155-5p, miR-155(*), and miR-146a-5p Expression in Graft vs. Host Disease
por: Crossland, Rachel E., et al.
Publicado: (2021)

Methylated Host Cell Gene Promoters and Human Papillomavirus Type 16 and 18 Predicting Cervical Lesions and Cancer
por: Milutin Gašperov, Nina, et al.
Publicado: (2015)

Chronic gvhd dictionary—eurograft cost action initiative consensus report
por: Zelić Kerep, Ana, et al.
Publicado: (2022)

Genome-wide miRNA profiling reinforces the importance of miR-9 in human papillomavirus associated oral and oropharyngeal head and neck cancer
por: Božinović, Ksenija, et al.
Publicado: (2019)

Methylation of Immune Gene Promoters in Oral and Oropharyngeal Cancer
por: Anić, Petra, et al.
Publicado: (2023)

Expression of Serum microRNAs is Altered During Acute Graft-versus-Host Disease
por: Crossland, Rachel E., et al.
Publicado: (2017)

Cell-based therapy in prophylaxis and treatment of chronic graft-versus-host disease
por: Doglio, Matteo, et al.
Publicado: (2022)

Tissue-Specific Expression Patterns of MicroRNA during Acute Graft-versus-Host Disease in the Rat
por: Jalapothu, Dasaradha, et al.
Publicado: (2016)

DNA Methylome Distinguishes Head and Neck Cancer from Potentially Malignant Oral Lesions and Healthy Oral Mucosa
por: Milutin Gašperov, Nina, et al.
Publicado: (2020)

Human Papillomaviruses-Associated Cancers: An Update of Current Knowledge
por: Pešut, Ena, et al.
Publicado: (2021)

Head and Neck Cancer Patients’ Survival According to HPV Status, miRNA Profiling, and Tumour Features—A Cohort Study
por: Šimić, Ivana, et al.
Publicado: (2023)

High frequency of cutaneous manifestations including vitiligo and alopecia areata in a prospective cohort of patients with chronic graft-vs-host disease
por: Čeović, Romana, et al.
Publicado: (2016)

Extracorporeal photopheresis as an immunomodulatory treatment modality for chronic GvHD and the importance of emerging biomarkers
por: Bojanic, Ines, et al.
Publicado: (2023)

Serum and Extracellular Vesicle MicroRNAs miR-423, miR-199, and miR-93* As Biomarkers for Acute Graft-versus-Host Disease
por: Crossland, Rachel E., et al.
Publicado: (2017)

Exploring the Extracellular Vesicle MicroRNA Expression Repertoire in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis Treated with TNF Inhibitors
por: Wielińska, Joanna, et al.
Publicado: (2021)

Post-transplant multimorbidity index and quality of life in patients with chronic graft-versus-host disease—results from a joint evaluation of a prospective German multicenter validation trial and a cohort from the National Institutes of Health
por: Wolff, Daniel, et al.
Publicado: (2020)

Correction: Post-transplant multimorbidity index and quality of life in patients with chronic graft-versus-host disease—results from a joint evaluation of a prospective German multicenter validation trial and a cohort from the National Institutes of Health
por: Wolff, Daniel, et al.
Publicado: (2021)

Extracorporeal photopheresis in acute and chronic steroid‑refractory graft-versus-host disease: an evolving treatment landscape
por: Greinix, Hildegard T., et al.
Publicado: (2022)

Milestones of Hematopoietic Stem Cell Transplantation – From First Human Studies to Current Developments
por: Juric, Mateja Kralj, et al.
Publicado: (2016)

Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation
por: Ogonek, Justyna, et al.
Publicado: (2016)

EBMT—NIH—CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment
por: Schoemans, Helene M., et al.
Publicado: (2018)

Cervical HPV type-specific pre-vaccination prevalence and age distribution in Croatia
por: Sabol, Ivan, et al.
Publicado: (2017)

Microbiota and Graft-versus Host disease: a double-edged sword
por: Holler, Ernst, et al.
Publicado: (2019)

Cyclophosphamide for salvage therapy of chronic graft-versus-host disease: a retrospective analysis
por: Fante, Matthias A., et al.
Publicado: (2020)

Adiponectin and resistin in acute and chronic graft-vs-host disease patients undergoing allogeneic hematopoietic stem cell transplantation
por: Robak, Oliver, et al.
Publicado: (2016)

IL6-receptor antibody tocilizumab as salvage therapy in severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a retrospective analysis
por: Kattner, Anna-Sophia, et al.
Publicado: (2020)

Joint and fascial chronic graft-vs-host disease: correlations with clinical and laboratory parameters
por: Vukić, Tamara, et al.
Publicado: (2016)

Parametric Imaging of Contrast-Enhanced Ultrasound (CEUS) for the Evaluation of Acute Gastrointestinal Graft-Versus-Host Disease
por: Pausch, Antonia-Maria, et al.
Publicado: (2021)

Successful Treatment of Recurrent Gastrointestinal Bleeding Due to Small Intestine Angiodysplasia and Multiple Myeloma with Thalidomide: Two Birds with One Stone
por: Hude, Ida, et al.
Publicado: (2018)

The lung function score and its components as predictors of overall survival and chronic graft-vs-host disease after allogeneic stem cell transplantation
por: Ditz, Diana, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_e8g5gu3m75euc6r31dp01t5glp